PROGNOSTIC FACTORS FOR LOCOREGIONAL RECURRENCES AFTER SUPRACRICOID LARYNGECTOMY
Abstract
Supracricoid laryngectomy, also named open partial horizontal laryngectomy type II (OPH II), involves resection of the ventricular folds, vocal folds, paraglottic space, thyroid cartilage, optionally up to one arytenoid cartilage, and, depending on whether it is an OPH II A or B, of the epiglottis. Locoregional control of the disease is a complex phenomenon that includes the characteristics of the tumor, the patient and genetic factors. This study aimed to identify factors indicating an increased possibility of locoregional recurrences following supracricoid laryngectomy.
Retrospective study included 104 patients who underwent supracricoid laryngectomy at the Otorhinolaryngology and Head and Neck Surgery Clinic of the University Clinical Center of Vojvodina in the period 2002–2020. Pathohistologically verified TN stage, thyroid cartilage invasion, positive margins, vascular invasion, positive Delphi lymph node and extranodal extension of metastatic disease were estimated as predictive factors for locoregional recurrences.
The median time for a local recurrence was 22 months (9.5–59.5), and the median time for regional recurrence was 21 months (10–38.5). Statistical significance in local recurrences of the disease was recorded in the presence of pathohistologically confirmed positive margins (p = 0.033) and vascular invasion (p = 0.029). The statistical significance of vascular invasion was also observed in regional (p = 0.041) and locoregional recurrences (p = 0.004). Pathohistologically confirmed higher T stage showed statistical significance in the occurrence of regional metastases (p = 0.035).
Pathohistologically confirmed vascular invasion stands out as an independent factor that should be paid attention to in further postoperative therapeutic care in order to achieve high-quality locoregional control of the disease, while in local control, along with vascular invasion, the importance of positive resection margins is also emphasized.
References
Allegra E, Bianco MR, Modica DM, Azzolina A, Privitera E, Latella D, et al. Multicentric study on oncological outcomes and prognostic factors of open partial horizontal laryngectomies. Ear, nose and troath journal 2024; 0(0):1-10. [CrossRef] [PubMed]
Arboleda LPA, Neves AB,Kohler HF, Vartanian JG, Candelaria LM, Borges MF, et al. Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer reports 2023;6:e1837. [CrossRef] [PubMed]
Baird BJ, Sung CK, Beadle BM, Divi V. Treatment of early-stage laryngeal cancer: A compariosn of treatment options. Oral Oncology. 2018;87:8-16. [CrossRef] [PubMed]
Brasnu DF. Supracricoid partial laryngectomy with cricohyoidopexy in the menagment of laryngeal carcinoma. World J Surg 2003;27(7):817-23. [CrossRef] [PubMed]
Bron L, Brossard E. Supracricoid partial laryngectomy with cricoidoepiglottopexy and cricohyoidopexy for glottic and supraglotic carcinoma. Laryngoscope 2000;110:627-34. [CrossRef] [PubMed]
Crosetti E, Bertolin A, Molteni G, Bertotto I, Balmativola D, Carraro M, et al. Patterns of recurrence after open partial horizontal laryngectomy types II and III: univariate and logistic regression analysis of risk factors. Acta otorhinolaryngologica italica 2019;39:235-43. [CrossRef] [PubMed]
De Vincentiis M, Greco A, Campo F, Candelori F, Ralli M, Di Traglia M, et al. Open partial horizontal laryngectomy for T2/T3/T4a laryngeal cancer: oncological outcomes and prognostic factors of two Italian hospitals. European Archives of Oto-Rhino-Laryngology 2022;279:2997-3004. [CrossRef] [PubMed]
Gallo A, Manciocco V, Simonelli M, Pagliuca G, D’Arcangelo E, De Vincentiis M. Supracricoid partial laryngectomy in the treatmen of laryngeal cancer. Univariate and Multivariate analysis of prognostic factors. Arch otolaryngol head and neck surg. 2005;131:620-5. [CrossRef] [PubMed]
Huang J, Chan CS, Ko S, Lok V, Zhang L, Lin X, et al. Update disease distributions, risk factors, and trends of laryngeal cancer: a global analysis of cancer registers. International journal of surgeru 2024;110:810-9. [CrossRef] [PubMed]
Mesolella M, Iorio B, Buono S, Cimmino M, Motta G. Supracricoid partial laryngectomy: Oncological and functional outcomes. Int arch otorhinolaryngol 2022;26(1):75-84. [CrossRef] [PubMed]
Obid R, Redlich M, Tomeh C. The treatment of laryngeal cancer. Oral Maxillofacial surg. 2019;31:1-11. [CrossRef] [PubMed]
Saturno M, Shaari AL, Yun J, Wein LE, Shaari D, Kappauf C, et al. Outcomes of supracricoid partial laryngectomy performed in the United States: A systematic review. The Laryngoscope 2024;134:3003-11. [CrossRef] [PubMed]
Succo G, Crosetti E, Bertolin A, Piazza C, Molteni G, Cirillo S, et al. Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of differen.t pathologic tumor subcategories. Head & Neck 2018;40(9):1897-908. [CrossRef] [PubMed]
Succo G, Crosseti E, Bertolin A, Lucioni M, Arrigoni G, Panetta V, et al. Intermediate and selected advanced stage laryngeal carcinoma. Head & Neck 2016;38:649-57. [CrossRef] [PubMed]
